Sean Lindsay McGee

Sean Lindsay McGee

Auto-generated profile, based on publicly available information

Sean Lindsay McGee

School of Medicine, Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC 3220, Australia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2008 in The Journal of Physiology
Verified
Journal Article
Closed access
KBKirsten A. Burgomaster
Kirsten A. Burgomaster
KHKrista R. Howarth
Krista R. Howarth
Stuart PhillipsStuart Phillips
Stuart Phillips
MRMark Rakobowchuk
Mark Rakobowchuk
MMMaureen J. MacDonald
Maureen J. MacDonald
MGMartin J. Gibala
Martin J. Gibala

1 April 2008 in Exercise and Sport Sciences Reviews
Verified
Journal Article
Closed access
MGMartin J. Gibala
Martin J. Gibala
SMSean L. McGee
Sean L. McGee
High-intensity interval training (HIT) is a potent time-efficient strategy to induce numerous metabolic adaptations usually associated with traditional endurance training. As little as six sessions of HIT over 2 wk or a total of only approximately 15 min of very intense exercise (approximately 600 kJ), can increase skeletal muscle oxidative capacity and endurance performance and alter metabolic control during aerobic-based exercise.

1 April 2008 in Diabetes
Verified
Journal Article
Open access
PDF file
SMSean L. McGee
Sean L. McGee
BDBryce J.W. van Denderen
Bryce J.W. van Denderen
KHKirsten Howlett
Kirsten Howlett
JMJanelle Mollica
Janelle Mollica
JSJonathan D. Schertzer
Jonathan D. Schertzer
MHMark Hargreaves
Mark Hargreaves
OBJECTIVE—Insulin resistance associated with obesity and diabetes is ameliorated by specific overexpression of GLUT4 in skeletal muscle. The molecular mechanisms regulating skeletal muscle GLUT4 expression remain to be elucidated. The purpose of this study was to examine these mechanisms. RESEARCH DESIGN AND METHODS AND RESULTS—Here, we report that AMP-activated protein kinase (AMPK) regulates GLUT4 transcription through the histone deacetylase (HDAC)5 transcriptional repressor. Overexpression of HDAC5 represses GLUT4 reporter gene expression, and HDAC inhibition in human primary myotubes increases endogenous GLUT4 gene expression. In vitro kinase assays, site-directed mutagenesis, and site-specific phospho-antibodies establish AMPK as an HDAC5 kinase that targets S259 and S498. Constitutively active but not dominant-negative AMPK and 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside (AICAR) treatment in human primary myotubes results in HDAC5 phosphorylation at S259 and S498, association with 14-3-3 isoforms, and H3 acetylation. This reduces HDAC5 association with the GLUT4 promoter, as assessed through chromatin immunoprecipitation assays and HDAC5 nuclear export, concomitant with increases in GLUT4 gene expression. Gene reporter assays also confirm that the HDAC5 S259 and S498 sites are required for AICAR induction of GLUT4 transcription. CONCLUSIONS—These data reveal a signal transduction pathway linking cellular energy charge to gene transcription directed at restoring cellular and whole-body energy balance and provide new therapeutic targets for the treatment and management of insulin resistance and type 2 diabetes.

1 March 2009 in Journal of Applied Physiology
Verified
Journal Article
Closed access
MGMartin J. Gibala
Martin J. Gibala
SMSean L. McGee
Sean L. McGee
AGAndrew P. Garnham
Andrew P. Garnham
KHKirsten Howlett
Kirsten Howlett
RSRodney J. Snow
Rodney J. Snow
MHMark Hargreaves
Mark Hargreaves
From a cell signaling perspective, short-duration intense muscular work is typically associated with resistance training and linked to pathways that stimulate growth. However, brief repeated sessions of sprint or high-intensity interval exercise induce rapid phenotypic changes that resemble traditional endurance training. We tested the hypothesis that an acute session of intense intermittent cycle exercise would activate signaling cascades linked to mitochondrial biogenesis in human skeletal muscle. Biopsies (vastus lateralis) were obtained from six young men who performed four 30-s “all out” exercise bouts interspersed with 4 min of rest (<80 kJ total work). Phosphorylation of AMP-activated protein kinase (AMPK; subunits α1 and α2) and the p38 mitogen-activated protein kinase (MAPK) was higher ( P ≤ 0.05) immediately after bout 4 vs. preexercise. Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA was increased approximately twofold above rest after 3 h of recovery ( P ≤ 0.05); however, PGC-1α protein content was unchanged. In contrast, phosphorylation of protein kinase B/Akt (Thr308 and Ser473) tended to decrease, and downstream targets linked to hypertrophy (p70 ribosomal S6 kinase and 4E binding protein 1) were unchanged after exercise and recovery. We conclude that signaling through AMPK and p38 MAPK to PGC-1α may explain in part the metabolic remodeling induced by low-volume intense interval exercise, including mitochondrial biogenesis and an increased capacity for glucose and fatty acid oxidation.

1 April 2014 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
TPTiffany J. Parmenter
Tiffany J. Parmenter
MKMargarete Kleinschmidt
Margarete Kleinschmidt
KKKathryn M. Kinross
Kathryn M. Kinross
SBSimon T. Bond
Simon T. Bond
Jason LiJason Li
Jason Li
Grant McarthurGrant Mcarthur
Grant Mcarthur
Deregulated glucose metabolism fulfills the energetic and biosynthetic requirements for tumor growth driven by oncogenes. Because inhibition of oncogenic BRAF causes profound reductions in glucose uptake and a strong clinical benefit in BRAF-mutant melanoma, we examined the role of energy metabolism in responses to BRAF inhibition. We observed pronounced and consistent decreases in glycolytic activity in BRAF-mutant melanoma cells. Moreover, we identified a network of BRAF-regulated transcription factors that control glycolysis in melanoma cells. Remarkably, this network of transcription factors, including hypoxia-inducible factor-1α, MYC, and MONDOA (MLXIP), drives glycolysis downstream of BRAFV600, is critical for responses to BRAF inhibition, and is modulated by BRAF inhibition in clinical melanoma specimens. Furthermore, we show that concurrent inhibition of BRAF and glycolysis induces cell death in BRAF inhibitor (BRAFi)–resistant melanoma cells. Thus, we provide a proof-of-principle for treatment of melanoma with combinations of BRAFis and glycolysis inhibitors. Significance: BRAFis suppress glycolysis and provide strong clinical benefit in BRAFV600 melanoma. We show that BRAF inhibition suppresses glycolysis via a network of transcription factors that are critical for complete BRAFi responses. Furthermore, we provide evidence for the clinical potential of therapies that combine BRAFis with glycolysis inhibitors. Cancer Discov; 4(4); 423–33. ©2014 AACR. See related commentary by Haq, p. 390 This article is highlighted in the In This Issue feature, p. 377

15 December 2009 in The Journal of Physiology
Verified
Journal Article
Closed access
SMSean L. McGee
Sean L. McGee
EFErin Fairlie
Erin Fairlie
AGAndrew P. Garnham
Andrew P. Garnham
MHMark Hargreaves
Mark Hargreaves